Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

All News Releases

Alexion Appoints Judith A. Reinsdorf, J.D., to its Board of Directors
February 5, 2018
HTML PDF
Alexion to Present at the Leerink Partners 7th Annual Global Healthcare Conference
January 31, 2018
HTML PDF
Alexion Appoints Deborah Dunsire, M.D. to Its Board of Directors
January 22, 2018
HTML PDF
Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018
January 18, 2018
HTML PDF
Alexion and Elliott Agree to Collaborate on Identifying a New Board Member
January 2, 2018
HTML PDF
Alexion to Present at the 36th Annual J.P. Morgan Healthcare Conference
January 2, 2018
HTML PDF
Soliris® (Eculizumab) Receives Marketing Authorization in Japan for the Treatment of Patients with Generalized Myasthenia Gravis (gMG)
December 26, 2017
HTML PDF
Alexion to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
December 20, 2017
HTML PDF
Results of Phase 1b/2 Dose Regimen Optimization Studies for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Presented at American Society of Hematology (ASH) Meeting
December 11, 2017
HTML PDF
Alexion and Halozyme Enter License Agreement for ENHANZE Technology
December 7, 2017
HTML PDF